+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ichthyosis Drug"

Congenital Ichthyosis - Pipeline Insight, 2024 - Product Thumbnail Image

Congenital Ichthyosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Ichthyosis - Pipeline Insight, 2024 - Product Thumbnail Image

Ichthyosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
Congenital ichthyosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congenital ichthyosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ichthyosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Ichthyosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Lamellar Ichthyosis (LI)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Lamellar Ichthyosis (LI)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

The Ichthyosis Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Ichthyosis is a group of rare, genetic skin disorders characterized by dry, scaly skin. Common treatments for Ichthyosis include topical creams, ointments, and oral medications. These drugs are used to reduce scaling, itching, and inflammation, as well as to improve skin hydration. The Ichthyosis Drug market is highly specialized, with a limited number of products available. As such, the market is dominated by a few large pharmaceutical companies. These companies are focused on developing new treatments and improving existing ones. Some of the major companies in the Ichthyosis Drug market include GlaxoSmithKline, Novartis, Pfizer, and Sanofi. These companies are actively researching and developing new treatments for Ichthyosis, as well as improving existing treatments. Show Less Read more